Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

Latest News

Tokyo 2020 must address questions, says IOC's Coates

Apr 23, 2018

By Jack TarrantTOKYO (Reuters) - John Coates, chairman of the IOC's Coordination Committee for the 2020 Tokyo Olympics, told organizers on Monday that stakeholders may lose confidence in their ability to host the Games if they do not answer questions about preparations.Speaking at the International Olympic Committee’s Project Review meeting in Tokyo, Coates said there would be no let-up from National Olympic Committees (NOCs) and international sporting federations in the run-up to the Games.“We enter a phase where questions from stakeholders become very pragmatic and very urgent,” said the Australian in his opening remarks ahead of the two-day meeting.“I wasn’t...

Asia stocks struggle with rising yields; oil stays high

Apr 23, 2018

By Wayne ColeSYDNEY (Reuters) - Asian stocks dipped on Monday as investors braced for a bevy of earnings from the world's largest corporations, while keeping a wary eye on U.S. bond yields as they approach peaks that have triggered market spasms in the past.Traders were also anxiously awaiting surveys on global manufacturing for April to see if economic softness in the first quarter was just a passing phase linked to poor weather and the Lunar New Year holidays.The first reading from Japan was tentatively upbeat with its PMI firming to 53.3 in April as output and domestic demand picked up.On...

Dollar edges higher, bolstered by rising U.S. yields

Apr 23, 2018

By Masayuki KitanoSINGAPORE (Reuters) - The dollar traded near a two-week high against a basket of major currencies on Monday, bolstered by rising U.S. bond yields, while easing concerns over global political risks weighed on the safe haven yen.The dollar's index against a basket of six major peers stood at 90.445 in early Asian trade, within sight of a two-week high of 90.477 set on Friday.Rising U.S. bond yields helped underpin the greenback, with the U.S. 10-year Treasury yield touching a peak of 2.968 percent , the highest since January 2014 in early Asian trade. That was up about 2...

ANZ to book $484 million charge on wealth business sales

Apr 23, 2018

(Reuters) - Australia and New Zealand Banking Group (ANZ) said it would book a loss of A$632 million ($484 million) on the divestment of two of its wealth businesses last year, which will be reflected in its half-year results.It sold its OnePath pensions and investments business to IOOF Holdings in October and its life insurance business to Zurich Insurance Group in December.The loss includes future separation and costs of completing the transactions of A$355 million, the bank said in a statement.ANZ also said legal costs relating to a Royal Commission inquiry into the banking sector were expected to be around...

Australian regulator flags scrutiny of Uber Eats

Apr 23, 2018

SYDNEY (Reuters) - The head of Australia's competition regulator said on Monday it will scrutinize contracts between Uber Technologies Inc [UBER.UL] and restaurants that use its food delivery app Uber Eats.The Australian Broadcasting Corporation reported on Sunday several restaurateurs were disgruntled with contract terms they said left them, and not Uber, responsible for late deliveries despite being charged by Uber for the service. "Certainly, we'll have a look at it," Rod Sims, head of the Australian Competition and Consumer Commission, told ABC radio on Monday when asked about the report."We have three bits of the law we can deal with...

Stock Markets

About Us

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

Contact us: sales[at]themorningherald.com

Subscribe Now!